Hepatic lipid peroxidation and cytochrome P-450 2E1 in pediatric nonalcoholic fatty liver disease and its subtypes

Journal of Clinical Gastroenterology

Volumn 45, Issue 9, 2011, Pages 800-807

  Bell, Lauren N ^a   Molleston, Jean P ^b   Morton, Michael J ^b   Klipsch, Ann ^b   Saxena, Romil ^a,b   Vuppalanchi, Raj ^a   Chalasani, Naga ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

cytochrome P 450 2E1; lipid peroxidation; nonalcoholic fatty liver disease; oxidative stress; pediatric

Indexed keywords

CYTOCHROME P450 2E1; MALONALDEHYDE;

ADULT; ARTICLE; BODY MASS; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HEPATITIS C; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD;

ADOLESCENT; BIOPSY; BODY MASS INDEX; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CYTOCHROME P-450 CYP2E1; FATTY LIVER; FEMALE; HUMANS; INFANT; LIPID PEROXIDATION; LIVER; MALE; MALONDIALDEHYDE; RETROSPECTIVE STUDIES;

EID: 80052918408     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0b013e31821377e4     Document Type: Article

References (33)

1. Shneider BL, Gonzalez-Peralta R, Roberts EA. Controversies in the management of pediatric liver disease: hepatitis B, C and NAFLD: summary of a single topic conference. Hepatology. 2006;44:1344-1354. (Pubitemid 44748385)
2. Schwimmer JB, Deutsch R, Kahen T, et al. Prevalence of fatty liver in children and adolescents. Pediatrics. 2006;118: 1388-1393. (Pubitemid 46393782)
3. Loomba R, Sirlin CB, Schwimmer JB, et al. Advances in pediatric nonalcoholic fatty liver disease. Hepatology. 2009;50: 1282-1293.
4. Suzuki D, Hashimoto E, Kaneda K, et al. Liver failure caused by non-alcoholic steatohepatitis in an obese young male. J Gastroenterol Hepatol. 2005;20:327-329. (Pubitemid 40343294)
5. Molleston JP, White F, Teckman J, et al. Obese children with steatohepatitis can develop cirrhosis in childhood. Am J Gastroenterol. 2002;97:2460-2462.
6. Yeh MM, Brunt EM. Pathology of nonalcoholic fatty liver disease. Am J Clin Pathol. 2007;128:837-847. (Pubitemid 350133997)
7. Schwimmer JB, Behling C, Newbury R, et al. Histopathology of pediatric nonalcoholic fatty liver disease. Hepatology. 2005; 42:641-649. (Pubitemid 41233657)
8. Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313-1321. (Pubitemid 40770284)
9. Patton HM, Lavine JE, Van Natta ML, et al. Clinical correlates of histopathology in pediatric nonalcoholic steatohepatitis. Gastroenterology. 2008;135:1961-1971 e1962.
10. Xanthakos S, Miles L, Bucuvalas J, et al. Histologic spectrum of nonalcoholic fatty liver disease in morbidly obese adolescents. Clin Gastroenterol Hepatol. 2006;4:226-232. (Pubitemid 43199694)
11. Nobili V, Marcellini M, Devito R, et al. NAFLD in children: a prospective clinical-pathological study and effect of lifestyle advice. Hepatology. 2006;44:458-465. (Pubitemid 44214885)
12. Carter-Kent C, Yerian LM, Brunt EM, et al. Nonalcoholic steatohepatitis in children: a multicenter clinicopathological study. Hepatology. 2009;50:1113-1120.
13. Robertson G, Leclercq I, Farrell GC. Nonalcoholic steatosis and steatohepatitis. II: cytochrome P-450 enzymes and oxidative stress. Am J Physiol Gastrointest Liver Physiol 2001; 281:G1135-G1139.
14. Sanyal AJ, Campbell-Sargent C, Mirshahi F, et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology. 2001;120: 1183-1192. (Pubitemid 32246672)
15. Chalasani N, Deeg MA, Crabb DW. Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis. Am J Gastroenterol. 2004;99:1497-1502. (Pubitemid 39193189)
16. MacDonald GA, Bridle KR, Ward PJ, et al. Lipid peroxidation in hepatic steatosis in humans is associated with hepatic fibrosis and occurs predominately in acinar zone 3. J Gastroenterol Hepatol. 2001;16:599-606. (Pubitemid 34188832)
17. Weltman MD, Farrell GC, Liddle C. Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation. Gastroenterology. 1996;111: 1645-1653. (Pubitemid 26404230)
18. Leclercq IA, Farrell GC, Field J, et al. CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis. J Clin Invest. 2000;105:1067-1075. (Pubitemid 30217691)
19. Chalasani N, Gorski JC, Asghar MS, et al. Hepatic cytochrome P450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis. Hepatology. 2003;37:544-550. (Pubitemid 36258775)
20. Weltman MD, Farrell GC, Hall P, et al. Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis. Hepatology. 1998;27:128-133. (Pubitemid 28041545)
21. Chtioui H, Semela D, Ledermann M, et al. Expression and activity of the cytochrome P450 2E1 in patients with nonalcoholic steatosis and steatohepatitis. Liver Int. 2007; 27:764-771. (Pubitemid 47062043)
22. Emery MG, Fisher JM, Chien JY, et al. CYP2E1 activity before and after weight loss in morbidly obese subjects with nonalcoholic fatty liver disease. Hepatology. 2003;38:428-435. (Pubitemid 36919864)
23. Ernstgard L, Warholm M, Johanson G. Robustness of chlorzoxazone as an in vivo measure of cytochrome P450 2E1 activity. Br J Clin Pharmacol. 2004;58:190-200. (Pubitemid 39044000)
24. Raucy JL, Lasker JM, Kraner JC, et al. Induction of cytochrome P450IIE1 in the obese overfed rat. Mol Pharmacol. 1991;39:275-280.
25. Machado M, Cortez-Pinto H. Nash, insulin resistance and iron. Liver Int. 2006;26:1159-1162.
26. Portal BC, Richard MJ, Faure HS, et al. Altered antioxidant status and increased lipid peroxidation in children with cystic fibrosis. Am J Clin Nutr. 1995;61:843-847.
27. Lepage G, Champagne J, Ronco N, et al. Supplementation with carotenoids corrects increased lipid peroxidation in children with cystic fibrosis. Am J Clin Nutr. 1996;64:87-93. (Pubitemid 26241961)
28. Baskol G, Baskol M, Kocer D. Oxidative stress and antioxidant defenses in serum of patients with non-alcoholic steatohepatitis. Clin Biochem. 2007;40:776-780. (Pubitemid 46961959)
29. Koruk M, Taysi S, Savas MC, et al. Oxidative stress and enzymatic antioxidant status in patients with nonalcoholic steatohepatitis. Ann Clin Lab Sci. 2004;34:57-62. (Pubitemid 38280304)
30. Vieira I, Sonnier M, Cresteil T. Developmental expression of CYP2E1 in the human liver: hypermethylation control of gene expression during the neonatal period. Eur J Biochem. 1996; 238:476-483.
31. Blanco JG, Harrison PL, Evans WE, et al. Human cytochrome P450 maximal activities in pediatric versus adult liver. Drug Metab Dispos. 2000;28:379-382. (Pubitemid 30185673)
32. Johnsrud EK, Koukouritaki SB, Divakaran K, et al. Human hepatic CYP2E1 expression during development. J Pharmacol Exp Ther. 2003;307:402-407. (Pubitemid 37151933)
33. Harman D. The free radical theory of aging. Antioxid Redox Signal. 2003;5:557-561.(Pubitemid 37315142)